Loading...
Quest Diagnostics Community
NYSE:DGX Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 24 Fair Values set on narratives written by author
Community Investing Ideas
DGX: Core Volume Momentum And New Blood Tests Will Drive Share Momentum
Key Takeaways Growth in advanced diagnostics, consumer wellness demand, and accretive acquisitions is driving higher test volumes, revenue, and expanding geographic reach. Automation, AI adoption, and health data analytics are improving productivity, margins, and positioning the company for sustainable, data-driven revenue opportunities.Read more
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AN
US$197.25
6.6% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
3.88% p.a.
Profit Margin
11.08%
Future PE
19.6x
Share price in 2028
US$239.84